Identification of post-mortem cerebrospinal fluid proteins as potential biomarkers of ischemia and neurodegeneration

被引:83
作者
Lescuyer, P
Allard, L
Zimmermann-Ivol, CG
Burgess, JA
Hughes-Frutiger, S
Burkhard, PR
Sanchez, JC
Hochstrasser, DF
机构
[1] Gneva Univ Hosp, LCCC, Biomed Proteom Res Grp, Clin Chem Lab, CH-1211 Geneva 14, Switzerland
[2] Gneva Univ Hosp, Toxicol Sect, Clin Chem Lab, CH-1211 Geneva, Switzerland
[3] Gneva Univ Hosp, Dept Neurol, CH-1211 Geneva 14, Switzerland
关键词
biomarker; brain damage; cerebrospinal fluid; neurodegeneration;
D O I
10.1002/pmic.200300822
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Only few biological markers are currently available for the routine diagnosis of brain damage-related disorders including cerebrovascular, dementia, and other neurodegenerative diseases. In this study, post-mortem cerebrospinal fluid samples were used as a model of massive brain insult to identify new markers potentially relevant for neurodegeneration. The protein pattern of this sample was compared to the one of cerebrospinal fluid from healthy subjects by two-dimensional gel electrophoresis. Using gel imaging, N-terminal microsequencing, mass spectrometry, and immunodetection techniques, we identified 13 differentially expressed proteins. Most of these proteins have been previously reported to be somehow associated with brain destruction or with the molecular mechanisms underlying certain neurodegenerative conditions. These data indicate that the identified proteins indeed represent potential biomarkers of brain damage. We recently showed that H-FABP, a protein highly homologous to E-FABP and A-FABP identified in this study, is a potential marker of Creutzfeldt-Jakob disease and stroke.
引用
收藏
页码:2234 / 2241
页数:8
相关论文
共 74 条
[1]   Melanie II - a third-generation software package for analysis of two-dimensional electrophoresis images: I. Features and user interface [J].
Appel, RD ;
Palagi, PM ;
Walther, D ;
Vargas, JR ;
Sanchez, JC ;
Ravier, F ;
Pasquali, C ;
Hochstrasser, DF .
ELECTROPHORESIS, 1997, 18 (15) :2724-2734
[2]   DETERMINATION OF S-100 AND GLIAL FIBRILLARY ACIDIC PROTEIN CONCENTRATIONS IN CEREBROSPINAL-FLUID AFTER BRAIN INFARCTION [J].
AURELL, A ;
ROSENGREN, LE ;
KARLSSON, B ;
OLSSON, JE ;
ZBORNIKOVA, V ;
HAGLID, KG .
STROKE, 1991, 22 (10) :1254-1258
[3]   Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism [J].
Bonifati, V ;
Rizzu, P ;
van Baren, MJ ;
Schaap, O ;
Breedveld, GJ ;
Krieger, E ;
Dekker, MCJ ;
Squitieri, F ;
Ibanez, P ;
Joosse, M ;
van Dongen, JW ;
Vanacore, N ;
van Swieten, JC ;
Brice, A ;
Meco, G ;
van Duijn, CM ;
Oostra, BA ;
Heutink, P .
SCIENCE, 2003, 299 (5604) :256-259
[4]   Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease [J].
Brenner, M ;
Johnson, AB ;
Boespflug-Tanguy, O ;
Rodriguez, D ;
Goldman, JE ;
Messing, A .
NATURE GENETICS, 2001, 27 (01) :117-120
[5]  
Burkhard PR, 2001, ELECTROPHORESIS, V22, P1826, DOI 10.1002/1522-2683(200105)22:9<1826::AID-ELPS1826>3.0.CO
[6]  
2-L
[7]   CSF detection of the 14-3-3 protein in unselected patients with dementia [J].
Burkhard, PR ;
Sanchez, JC ;
Landis, T ;
Hochstrasser, DF .
NEUROLOGY, 2001, 56 (11) :1528-1533
[8]   Epidemiology of stroke [J].
Carolei, A ;
Sacco, S ;
De Santis, F ;
Marini, C .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 2002, 24 (7-8) :479-483
[9]   Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part 1: Creatine kinase bb, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1 [J].
Castegna, A ;
Aksenov, M ;
Aksenova, M ;
Thongboonkerd, V ;
Klein, JB ;
Pierce, WM ;
Booze, R ;
Markesbery, WR ;
Butterfield, DA .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 (04) :562-571
[10]   Recent advances in the pre-mortem diagnosis of Creutzfeldt-Jakob disease [J].
Collins, S ;
Boyd, A ;
Fletcher, A ;
Gonzales, MF ;
McLean, CA ;
Masters, CL .
JOURNAL OF CLINICAL NEUROSCIENCE, 2000, 7 (03) :195-202